옵션
집 AI 프롬프트 목록 의료 건강 처방전 감사 어시스턴트

처방전 감사 어시스턴트

{:__('collect %s',처방전 감사 어시스턴트)}

AI 기술을 활용하여 약사의 조제 전 처방전 검토를 지원하고, 잠재적인 약물 상호작용, 용량 이상 및 금기 사항을 식별하여 투약 안전성과 효율성을 향상시킵니다.

프롬프트 내용 복사 복사

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the impact of NSAIDs on renal function and the combined risk with antiplatelet agents, and provide specific adjustment suggestions or warning information to ensure the safety and efficacy of the medication regimen.

복사 복사

시니어 임상 약사로서 다음 전자 처방전의 준법성을 검토하십시오. 환자는 65세 남성으로, 고혈압 2기 및 경도 신기능 부전(eGFR 45ml/min) 진단을 받았습니다. 현재 복용 약물에는 아밀로디핀 5mg qd, 아스피린 100mg qd, 그리고 새로 처방된 이부프로펜 400mg tid이 포함됩니다. 이 처방전에 약물-질량 금기, 약물-약물 상호작용 또는 용량 조정 필요성이 포함되어 있는지 분석하고, 특히 NSAIDs의 신기능에 대한 영향과 항혈소판제와의 병용 위험에 초점을 맞추어, 투약 레지멘의 안전성과 유효성을 보장하기 위한 구체적인 조정 제안 또는 경고 정보를 제공하십시오.

복사 복사
의견 (0)
0/300

추천

처방전 심사 보조
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness, while flagging any risks according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations.
처방 심사 어시스턴트
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's hepatic and renal function status. Identify any risk points based on the latest clinical guidelines, and finally provide adjustment suggestions or confirm safety, ensuring the output is concise and clinically actionable.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions to ensure patient safety.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and dosage appropriateness, especially for elderly patients or those with hepatic/renal impairment. Highlight any high-risk combinations and provide alternative solutions or medication warnings based on the latest clinical guidelines, ensuring the output is concise and directly supports the pharmacy review workflow.
처방전 심사 어시스턴트
Act as a senior clinical pharmacist reviewing prescriptions in an electronic health record system. Based on the patient's diagnosis, medical history, allergies, and concurrent medications, strictly verify the appropriateness of drug indications, dosages, routes, and durations against current clinical guidelines and package inserts. Focus on identifying potential drug-drug interactions, drug-disease contraindications, and necessary dose adjustments for special populations such as those with hepatic or renal impairment. If any risks or non-compliance issues are found, clearly specify the problem and provide evidence-based optimization suggestions or alternative regimens. Finally, output a structured, professional audit report to ensure medication safety and efficacy.
처방전 검토 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract drug names, dosages, routes, and frequencies, cross-referencing them with the patient's age, gender, renal/hepatic function, and medical history. Second, check for contraindicated combinations or severe adverse reaction risks using drug interaction databases, especially for vulnerable populations like the elderly or pregnant women. Finally, if dose exceedance, duplicate therapy, or drug-disease contraindications are found, clearly identify the risks and provide optimization suggestions aligned with the latest clinical guidelines to ensure safety, efficacy, and cost-effectiveness.
OR